Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.
暂无分享,去创建一个
E. Dmitrovsky | D. Scheinberg | R. Warrell | W. Miller | A. Jakubowski | S. Frankel | C. Young | J. Muindi | J. Muindi
[1] R. Warrell,et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. , 1992, Cancer research.
[2] Zi X. Chen,et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. , 1991, Blood.
[3] E. Dmitrovsky,et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.
[4] H Nau,et al. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[5] L. Gudas,et al. Overexpression of the cellular retinoic acid binding protein-I (CRABP- I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells , 1991, The Journal of cell biology.
[6] E. Dmitrovsky,et al. Novel retinoic acid receptor-alpha transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid. , 1990, Journal of the National Cancer Institute.
[7] M. Pratt,et al. A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell , 1990, Molecular and cellular biology.
[8] P. Pandolfi,et al. Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias , 1990, The Journal of experimental medicine.
[9] R Berger,et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.
[10] Christine Chomienne,et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.
[11] S. Collins,et al. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) , 1990, Molecular and cellular biology.
[12] D. Liberato,et al. Quantification of endogenous retinoic acid in human plasma by liquid chromatography/mass spectrometry , 1990 .
[13] J. Monbaliu,et al. Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats. , 1990, The Journal of pharmacology and experimental therapeutics.
[14] J. Saurat,et al. Isotretinoin differs from other synthetic retinoids in its modulation of human cellular retinoic acid binding protein (CRABP) , 1989, The British journal of dermatology.
[15] J. Saurat,et al. Ligand‐specific and non‐specific in vivo modulation of human epidermal cellular retinoic acid binding protein (CRABP) , 1989, European journal of clinical investigation.
[16] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[17] J. Saurat,et al. Plasma and skin carriers for natural and synthetic retinoids. , 1987, Archives of dermatology.
[18] M. Haussler,et al. Saturation analysis of cellular retinoid binding proteins: application to retinoic acid resistant human neuroblastoma cells and to human tumors. , 1987, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[19] F. Vane,et al. Determination of isotretinoin or etretinate and their major metabolites in human blood by reversed-phase high-performance liquid chromatography. , 1985, Journal of pharmaceutical and biomedical analysis.
[20] J. Kalin,et al. Effects of phenobarbital, 3-methylcholanthrene, and retinoid pretreatment on disposition of orally administered retinoids in mice. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[21] W. Colburn,et al. Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review. , 1982, Journal of the American Academy of Dermatology.
[22] H. Koeffler,et al. Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. , 1982, The Journal of clinical investigation.
[23] J. Kalin,et al. Disposition of all-trans-retinoic acid in mice following oral doses. , 1981, Drug metabolism and disposition: the biological fate of chemicals.
[24] M. Sporn,et al. In vitro metabolism of retinoic acid in hamster intestine and liver. , 1979, The Journal of biological chemistry.
[25] M. Sporn,et al. Retinoid-dependent induction of the in vivo and in vitro metabolism of retinoic acid in tissues of the vitamin A-deficient hamster. , 1979, The Journal of biological chemistry.